Influenza Vaccines

"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains.

Descriptor ID	D007252
MeSH Number(s)	D20.215.894.899.302
Concept/Terms	Influenza Vaccines Influenza Vaccines Influenza Vaccine Vaccine, Influenza Flu Vaccines Influenzavirus Vaccines Influenza Virus Vaccines Influenza Virus Vaccine Vaccine, Influenza Virus Virus Vaccine, Influenza High-Dose Trivalent Influenza Vaccine High-Dose Trivalent Influenza Vaccine High Dose Trivalent Influenza Vaccine Monovalent Influenza Vaccines Monovalent Influenza Vaccines Influenza Vaccines, Monovalent Vaccines, Monovalent Influenza Trivalent Influenza Vaccine Trivalent Influenza Vaccine Influenza Vaccine, Trivalent Vaccine, Trivalent Influenza Intranasal Live-Attenuated Influenza Vaccine Intranasal Live-Attenuated Influenza Vaccine Intranasal Live Attenuated Influenza Vaccine Universal Flu Vaccines Universal Flu Vaccines Universal Influenza Vaccines Trivalent Live Attenuated Influenza Vaccine Trivalent Live Attenuated Influenza Vaccine LAIV Vaccine Vaccine, LAIV Quadrivalent Influenza Vaccine Quadrivalent Influenza Vaccine Influenza Vaccine, Quadrivalent Vaccine, Quadrivalent Influenza

Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Viral Vaccines [D20.215.894.899]
Influenza Vaccines [D20.215.894.899.302]

Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.

Bar chart showing 45 publications over 19 distinct years, with a maximum of 7 publications in 2012 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1999	1	0	1
2000	1	0	1
2001	2	0	2
2004	0	1	1
2007	1	0	1
2008	1	0	1
2009	1	1	2
2010	2	0	2
2011	4	0	4
2012	4	3	7
2013	6	1	7
2014	1	0	1
2015	1	0	1
2017	2	1	3
2018	1	0	1
2020	1	0	1
2021	4	0	4
2022	4	0	4

Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.

Ng DQ, Jia S, Wisseh C, Cadiz C, Nguyen M, Lee J, McBane S, Nguyen L, Chan A, Hurley-Kim K. Sociodemographic characteristics differ across routine adult vaccine cohorts: An All of Us descriptive study. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):582-591.e20.

View in: PubMed
Morales CG, Jimenez NR, Herbst-Kralovetz MM, Lee NR. Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women. Med Sci (Basel). 2022 09 13; 10(3).

View in: PubMed
Bazargan M, Martinez-Hollingsworth A, Cobb S, Kibe LW. Correlates of influenza vaccination among underserved Latinx middle-aged and older adults: a cross-sectional survey. BMC Public Health. 2022 05 06; 22(1):907.

View in: PubMed
Are A, Hauser R, Spencer R, Satterfield J, Nguyen E. States' pharmacist immunization authority and the impact on adult influenza vaccination rates. J Am Pharm Assoc (2003). 2022 Sep-Oct; 62(5):1666-1670.e1.

View in: PubMed
Payne AB, Adamkiewicz TV, Grosse SD, Steffens A, Shay DK, Reed C, Schieve LA. Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009-2015. Pediatr Blood Cancer. 2021 12; 68(12):e29351.

View in: PubMed
Yamin D, Kahana D, Shahmoon E, Fitzpatrick MC, Galvani AP. Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy. BMC Public Health. 2021 08 12; 21(1):1543.

View in: PubMed
Elsobky Y, Nganwa D, El Afandi G, Byomi A, Reddy G, Abdalla E. A quantitative risk assessment to evaluate the efficacy of mitigation strategies to reduce highly pathogenic avian influenza virus, subtype H5N1 (HPAI H5N1) in the Menoufia governorate, Egypt. BMC Vet Res. 2021 Jun 07; 17(1):210.

View in: PubMed
Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, Marriott JJ, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study. CMAJ Open. 2021 Apr-Jun; 9(2):E510-E521.

View in: PubMed
Bazargan M, Wisseh C, Adinkrah E, Ameli H, Santana D, Cobb S, Assari S. Influenza Vaccination among Underserved African-American Older Adults. Biomed Res Int. 2020; 2020:2160894.

View in: PubMed
Olanipekun T, Effoe VS, Olanipekun O, Igbinomwanhia E, Kola-Kehinde O, Fotzeu C, Bakinde N, Harris R. Factors influencing the uptake of influenza vaccination in African American patients with heart failure: Findings from a large urban public hospital. Heart Lung. 2020 May - Jun; 49(3):233-237.

View in: PubMed

People

Explore

Similar Concepts

Top Journals